The role of immune checkpoint inhibition in triple negative breast cancer
Last Updated: Friday, July 17, 2026
Data from the numerous trials that evaluated the role of immune checkpoint inhibition (ICI) monotherapy, dual therapy, ICI in combination with chemotherapy, targeted therapy, vaccines, and radiation in TNBC treatment are reviewed here, along with potential biomarkers of response and immune-related adverse events.
Advertisement
News & Literature Highlights
